Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-120 for Uremic Pruritus in Hemodialysis Patients
NCT04639674Phase 4Completed
- Sponsor
- CONMED
- Start
- Jul 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of activated charcoal in uremic pruritus (2 arms), sponsored by CONMED. Primary endpoint: Visual Analog Scale at 2 months. Started Jul 2020; status: completed.
02
Drugs
activated charcoal
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT04639674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04639674.